Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.

Prescott LF, Buhs RP, Beattie JO, Speth OC, Trenner NR, Lasagna L.

Circulation. 1966 Aug;34(2):308-21. No abstract available.

PMID:
5969361
2.

The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.

Au WY, Dring LG, Grahame-Smith DG, Isaac P, Williams RT.

Biochem J. 1972 Aug;129(1):1-10.

3.

Metabolic disposition of methyldopa in hypertensive and renal-insufficient children.

O'Dea RF, Mirkin BL.

Clin Pharmacol Ther. 1980 Jan;27(1):37-43.

PMID:
7351116
4.

3-O-methyldopa, a new precursor of dopamine.

Bartholini G, Kuruma I, Pletscher A.

Nature. 1971 Apr 23;230(5295):533-4. No abstract available.

PMID:
4927759
5.

Alpha-methyldopa and drug fever. A study of the metabolism of alpha-methyldopa in patients and normal subjects.

Valnes K, Hillestad L, Hansen T, Arnold E.

Acta Med Scand. 1978;204(1-2):21-5.

PMID:
685725
6.
7.

A comparative study of metoprolol and methyldopa in the treatment of hypertension.

Karachalios GN.

Int J Clin Pharmacol Ther Toxicol. 1983 Sep;21(9):476-8.

PMID:
6629553
8.
9.

Study of phonocardiographic and apex cardiographic abnormalities in hypertensive disease and their responsiveness to alpha-methyldopa.

Strausz I, Kékes E, Horányi P, Barcsák J.

Ther Hung. 1973;21(3-4):97-100. No abstract available.

PMID:
4806428
10.

Conjugation of methyldopa in renal failure.

Myhre E, Stenbaek O, Brodwall EK, Hansen T.

Scand J Clin Lab Invest. 1972 Apr;29(2):195-9. No abstract available.

PMID:
5029323
11.

[Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].

Beretta R, Cassi E, Colombo A, De Paoli A, Marciandi C, Renzetti GA.

Clin Ter. 1982 Dec 15;103(5):487-500. Italian. No abstract available.

PMID:
7160141
12.

Effects of methyldopa in fifty hypertensive patients.

Horwitz D, Pettinger WA, Orvis H, Thomas RE, Sjoerdsma A.

Clin Pharmacol Ther. 1967 Mar-Apr;8(2):224-34. No abstract available.

PMID:
6021583
13.

[Clinical evaluation of antihypertensive treatment with alpha-methyldopa in patients with arterial hypertension and diabetes mellitus].

Stornello M, Di Rao G, Iachello M, Bosco V, Pantano S, Scapellato L.

Clin Ter. 1982 May 15;101(3):257-65. Italian. No abstract available.

PMID:
7094550
14.

[The combined use of alpha-methyldopa and butizide in the treatment of arterial hypertension].

Gobbi A, Reguzzoni G, Bonzi G.

Clin Ter. 1981 May 15;97(3):283-90. Italian. No abstract available.

PMID:
7285534
15.
16.

Guanadrel sulfate compared with methyldopa for mild and moderate hypertension.

Nugent CA, Palmer JD, Ursprung JJ.

Pharmacotherapy. 1982 Nov-Dec;2(6):378-83.

PMID:
6762533
17.

The metabolism of L-3-O-methyldopa, a precursor of dopa in man.

Kuruma I, Bartholini G, Tissot R, Pletscher A.

Clin Pharmacol Ther. 1971 Jul-Aug;12(4):678-82. No abstract available.

PMID:
5567811
18.

[100 hypertensive patients treated with methyldopa. Therapeutical experience].

Pellanda RJ, Pastoriza FE, Altamira J.

Prensa Med Argent. 1968 Apr 5;55(6):292-304. Spanish. No abstract available.

PMID:
5740843
19.
20.

Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.

del Greco F, Huang CM, Quintanilla A.

J Cardiovasc Pharmacol. 1981;3 Suppl 2:S99-103.

PMID:
6172673

Supplemental Content

Support Center